Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7448 p460
21 April 2007

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

• White Paper (5)
• Pseudoephedrine (2)
• Eczema
• Chemotherapy
• Community pharmacy (2)
• Locum pharmacy
• Packaging
• Dispensing
• MDS
• Parallel imports
• Prescription charges
• The Society
• Skill mix
• Professionalism
• Boots travel insurance


Letters to the Editor

The Society

Our Registrar should be on our Register

From Mr J. E. Balmford, FRPharmS

Probably along with many other members I could not believe my eyes when I read the advertisement on pA19 of The Journal of 31 March. I might have understood it if The Journal had borne the date 1 April.

To advertise for a chief executive officer at this time, at a six-figure salary, not specifying a pharmacist and having no indication that the post would be of limited duration, is absolute madness. If the person is to act as Registrar of our Royal Pharmaceutical Society, then that person must be on our Register.

I must commend the letter from Ian Caldwell, in the same issue of The Journal (p366), for setting out the position in which we find ourselves with the retirement of Ann Lewis in the autumn. When the split comes, as it surely will, then we, as the Society, will not require such a high powered person to run the new organisation and, therefore, the contract we offer must be limited.

The idea of a General Pharmaceutical Council seeking some of the Society’s assets when the split comes must be resisted at all costs. Our forebears, by good housekeeping, enabled us to have these possessions and they belong to the members.

I am also concerned that the Carter Working Party consists heavily of people from the Department of Health and that the Government will push through all that it wants regardless of the views of pharmacists.

John E. Balmford
Past President and Past Honorary Auditor
Royal Pharmaceutical Society

Send your letter to The Editor

Previous Topic (Prescription charges)
Next Topic (Skill mix)

Back to Top


©The Pharmaceutical Journal